N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
Main Authors: | Kasperzyk, J, d'Azzo, A, Platt, F, Seyfried, T |
---|---|
פורמט: | Conference item |
יצא לאור: |
2004
|
פריטים דומים
-
N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
מאת: Kasperzyk, J, et al.
יצא לאור: (2004) -
"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
מאת: Kasperzyk, J, et al.
יצא לאור: (2005) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
מאת: Baek, R, et al.
יצא לאור: (2008) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
מאת: Baek, R, et al.
יצא לאור: (2004) -
Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
מאת: Kasperzyk, J, et al.
יצא לאור: (2005)